Press release
Global Infectious Disease Drug Market Trends, Size, Forecast - 2019-2025
The global infectious disease drug market is estimated to grow at a CAGR of over 4% during the forecast period. Infectious diseases are those which are caused by different organisms such as bacteria, virus, fungi, and parasites. Some of the majorly occurring diseases that create scope for the market include Hepatitis, Pneumonia, Malaria, HIV/AIDS, Tuberculosis, E. Coli, Dengue, Influenza, Measles, and Typhoid, among others such as COVID–19, Zica, and Ebola. Influenza is a viral infection that is transmitted easily from person to person. This virus circulates globally and has the potential to infect the person of any age group. According to the Centers for Disease Control and Prevention in the US, there were 7,000 confirmed cases of the flu in 2017.Request a free sample of our report on Global Infectious Disease Drug Market: https://www.omrglobal.com/request-sample/infectious-disease-drug-market
HIV/AIDS is one of the most chronic diseases that result in a huge number of mortalities globally. The major reason behind this is inadequate access to HIV prevention care and treatment services. However, there is a rapid decline in new HIV infections among children (around 66% since 2000), attributed to the scale-up efforts for the prevention of mother-to-child transmission. In addition, Ebola virus disease (EVD) is another infectious disease that in recent years has become a great threat to humans globally. The 2014 Ebola epidemic in West Africa caused several mortalities and attracted global attention. Thus, the increased prevalence of such severe diseases is expected to create scope for the global infectious disease drug market during the forecast period.
A full report of Global Infectious Disease Drug Market Is available at :
https://www.omrglobal.com/industry-reports/infectious-disease-drug-market
Global Infectious Disease Drugs Market Segmentation
By Disease Type
• Bacterial Disease
• Viral Disease
• Fungal Disease
• Parasitic Disease
By Treatment Type
• Antibacterial
• Antiparasitic
• Antiviral
• Antifungal
• Others (Alternative Medicines)
Regional Analysis
• North America
o United States
o Canada
• Europe
o UK
o Germany
o Italy
o Spain
o France
o Rest of Europe
• Asia-Pacific
o China
o India
o Japan
o Rest of Asia-Pacific
• Rest of the World
Company Profiles
• AbbVie Inc.
• Allergan Plc
• Amgen Inc.
• Bayer AG
• BioCryst Pharmaceuticals, Inc.
• Boehringer Ingelheim GmbH
• Bristol-Myers Squibb Co.
• Eli Lilly & Co.
• F. Hoffmann-La Roche Ltd.
• Gilead Sciences, Inc.
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/infectious-disease-drug-market
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
About us:
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting, and other research-based services.
For More Information, Visit https://www.omrglobal.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Infectious Disease Drug Market Trends, Size, Forecast - 2019-2025 here
News-ID: 2106809 • Views: …
More Releases from Orion Market Research

Road Marking Paint Market : A Guide to Understanding the Process
The Road Marking Paint Market, valued at approximately USD 5.02 billion in 2023, is projected to reach around USD 7.69 billion by 2033, growing at a compound annual growth rate (CAGR) of 4.36% from 2024 to 2033.
Road Marking Paint Market Overview
The Road Marking Paint Market is steadily expanding, driven by burgeoning infrastructure investments and the need for improved road safety. Governments and municipalities are increasingly allocating funds toward both new…

Outboard Boat Market Size Analysis, Competitive Insights, Leading Players and Gr …
The Outboard Boats Market, valued at approximately USD 5.74 billion in 2023, is projected to grow to around USD 14 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 9% over the 2024-2033 period.
Outboard Boat Market Overview
The Outboard Boat Market continues to expand robustly, fueled largely by rising demand for recreational boating, favorable economic conditions, and the appeal of leisure marine activities. Innovations in outboard motor technology-including…

Mobile Ticketing Market Size Analysis, Competitive Insights, Leading Players and …
The Mobile Ticketing Market, valued at about USD 2.9 billion in 2023, is anticipated to grow to approximately USD 11.39 billion by 2033, reflecting a robust CAGR of 16.7% from 2024 to 2033.
Mobile Ticketing Market Overview
The Mobile Ticketing Market is undergoing rapid expansion, driven primarily by the global surge in smartphone usage and consumer preference for contactless, digital experiences. This growth is further propelled by widespread adoption of digital payments,…

Metal Alloy Market Size Analysis, Competitive Insights, Leading Players and Grow …
The Metal Alloy Market, valued at approximately USD 301.7 billion in 2023, is projected to reach USD 533.9 billion by 2033, growing at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2033.
Metal Alloy Market Overview
The Metal Alloy Market is experiencing steady, long-term expansion, driven by growing demand from key sectors such as automotive, aerospace, construction, and electronics. Applications in next-generation vehicles and aircraft are pushing interest in…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…